MaxCyte, Inc.

The Oslo Cancer Cluster seminar is just around the corner! Join us on Tuesday, May 20, 2025 for an in-person event featuring Dr. Anna Pasetto, Director of the ACT Centre at Oslo University Hospital. Dr. Pasetto will share her insights on accelerating cell-based immunotherapies through non-viral technologies, with a focus on clinical readiness and real-world application. Space is limited - Reserve your spot today https://lnkd.in/dNbZy3uA #Celltherapy #GeneTherapy #Electroporation #nonviral

ASGCT 2025 Is Underway—Let’s Connect in New Orleans! The welcome reception has wrapped, and the MaxCyte team is ready for a full week of conversations, insights, and scientific exchange at #ASGCT2025. Did you know SeQure DX is now part of MaxCyte? Come and learn more! Stop by Booth #1545 to explore how we can support efficient, scalable, and safe non-viral cell engineering—no matter where you are in development. Join our featured presentation: How to mitigate gene editing program risk through comprehensive off-target safety profiling and characterization with SeQure DX and Papillon Therapeutics. Thursday, May 15, 2025, from 12:15 to 1:15 p.m. CT in Room 271-273 Looking forward to connecting with you in New Orleans! Marissa Johnson Caroline A Romanelli Daniel Miller Jordan Villiet Daniel Nguyen Isabel Daher Lauren Unsworth James Brady Maxwell Van Buskirk Ashley Strickland-Dietz, Ph.D. Vijetha Vemulapalli Thomas Mullen Douglas Smith Delphine Caraguel #MaxCyte #CellTherapy #GeneTherapy #SeQureDX #ASGCT2025

We’re excited to announce that Chayon Laboratories, Inc., MaxCyte’s trusted distributor in Korea, is hosting a special webinar on May 13th at 10:00 AM (KST)! This session is designed for researchers in Korea and will cover innovative techniques for antibody discovery and protein production using MaxCyte’s cutting-edge technologies. Featured Speaker: Masahisa Ohishi, Senior Field Applications Scientist at MaxCyte What You’ll Learn: - MaxCyte Electroporation: How it accelerates protein development - Scalable transfection techniques for CHO cells (ExpiCHO, CHOZN, CHOK1) - Flexible protein expression strategies and tailored culture methods - Applications like mammalian display, high-throughput screening, and stable bulk pool development The presentation and Q&A will be delivered in English by Masa, while Chayon will guide the session in Korean to ensure smooth communication and local engagement. Register now: https://lnkd.in/eRtQNB9N 여러분의 많은 관심과 참여 부탁드립니다! #MaxCyte #Chayon #Webinar #ProteinDevelopment #AntibodyDiscovery #Electroporation #KoreanResearchers

At MaxCyte, our mission is rooted in human health—and on Mother’s Day, we’re reminded of the personal reasons that drive so many of us in this field. Whether it’s a mother fighting cancer, a scientist inspired by hers, or a patient hoping to become one—today, we honor the strength, care, and resilience of mothers everywhere. To all the mothers in labs, in clinics, and in our communities: thank you. You inspire our pursuit of therapies that can change lives. #MothersDay #CellTherapy #WomenInSTEM

ISCT 2025 is off to a great start! We’re excited to connect with the cell and gene therapy community this week in New Orleans. 👉 Stop by Booth #736 for a sweet treat—and stay to experience the ExPERT™ platform live in action: ✅ Today, Thursday, May 8 at 10:30am & 3:30pm ✅ Friday, May 9 at 10:30am 📅 Featured Presentation tomorrow: Friday, May 9, 2025 | 12:45–1:45pm CST | Room MR 217–219 Key Considerations in Early Cell Therapy Development to Mitigate Risk and Drive Faster Clinical Success with Dr. Matthew Porteus & Jason Skowronski of Kamau Therapeutics We hope to see you there! Victoria Zellmer, Ph.D. Genevieve Soares Nitin Kulkarni Joseph White Colleen Chilson Sean Menarguez Thomas Mullen Diwash Acharya, PhD Ali Soleymannezhad Marissa Johnson #CellTherapy #GeneEditing #Electroporation #ISCT2025 #MaxCyte

Heading to ASGCT 2025? So Are We—And We’ve Got a Full Agenda. Join MaxCyte® at Booth #1545 from May 13–17 at the Ernest N. Morial Convention Center in New Orleans as we spotlight our support for cell and gene therapy innovators across every phase of development. Experience our ExPERT™ Electroporation Platform hands-on Explore our scientific posters Don’t miss our partner talk with SeQure DX and Papillon Whether you're accelerating discovery or preparing for scale, let’s connect on how MaxCyte’s proven non-viral technology can help you navigate the journey from concept to clinic—and beyond. 📅 View the full event agenda: 🔗 https://lnkd.in/egYSGdj4 #MaxCyte #ASGCT2025 #ExPERTelectroporation #CellTherapy #GeneTherapy

Congratulations Dr. Kazuo Takayama for starting a new laboratory at the Institute of Science Tokyo (https://www.ktakayama.com/)! Our FAS team in Japan looks forward to standing alongside Dr. Takayama and his team, supporting their success in pioneering gene editing research every step of their journey! MaxCyteは、高山和雄先生の東京科学大学へのご栄転を心よりお祝い申し上げます (https://www.ktakayama.com/) 弊社日本ベースのFASチーム一同、これからも高山先生や研究室の皆様のゲノム編集における新たな挑戦を、全力でサポートしてまいります！ Peter Gee, Masahisa Ohishi Lucy Yang, PhD #GeneEditing #FASinJapan #MaxCyte

We are excited to share MaxCyte’s perspective with Biocompare on the evolving landscape of cell therapy. In this article, Dr. James Brady, SVP of Technical Applications & Customer Support at MaxCyte, discusses the promise and complexity of autologous and allogeneic approaches, and how enabling technologies like electroporation are supporting more efficient and scalable development of next-generation therapies. Read the full article to learn more about: - How autologous and allogeneic therapies differ in their clinical and manufacturing considerations - What factors are driving increased interest in off-the-shelf allogeneic treatments - How advanced non-viral delivery systems are unlocking new possibilities in cell therapy development https://bit.ly/4jEi5QU #CellTherapy #Autologous #Allogeneic #Electroporation #MaxCyte #CellEngineering

Come meet the team in Napa, CA this week. Genevieve Soares James Brady Martina Velichkovska

Visit MaxCyte at ISCT 2025 and experience the power of the ExPERT™ Electroporation Platform, built on our proven Flow Electroporation® technology. From discovery to commercialization, we help cell therapy innovators navigate every step with confidence. Stop by Booth #736 for a treat—and stay for a live demo! See the ExPERT platform in action: ✅ Wednesday, May 7 at 7:30pm ✅ Thursday, May 8 at 10:30am & 3:30pm ✅ Friday, May 9 at 10:30am 📅 Join our featured presentation on Friday, May 9, 2025 | 12:45–1:45pm CST | Room MR 217–219: Key Considerations in Early Cell Therapy Development to Mitigate Risk and Drive Faster Clinical Success with speakers Dr. Matthew Porteus & Jason Skowronski of Kamau Therapeutics. Discover how strategic platform selection, cross-functional collaboration, and data integration can accelerate your pathway to the clinic—while balancing innovation, scalability, and risk reduction. 👉 Let’s chart a clearer path to the clinic—together. Victoria Zellmer, Ph.D. Nitin Kulkarni Colleen Chilson Genevieve Soares Joseph White Sean Menarguez Ali Soleymannezhad Marissa Johnson #ISCT2025 #CellTherapy #GeneTherapy #NonViral #Electroporation